Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

A worldwide study of care and quality of life in atopic dermatitis

Looks at care, treatment and daily life of people with atopic dermatitis.

Key facts

Who runs it
Julia Tatjana Maul
Where
Zurich, SwitzerlandSee the site
Trial code
Registry title
Global Healthcare Study on Atopic Dermatitis
Status
Recruiting
People taking part
9,600 people, planned
Started
1 Jan 2025
Expected to end
31 Dec 2029
Type of study
Observational
Record updated
22 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with a confirmed diagnosis of atopic dermatitis (eczema) who have signed a general consent form. It is an observational study using routine medical records.

Age
14 Years and older
Sex
All sexes can join.
Disease stage
Confirmed diagnosis of atopic dermatitis. No stage or severity is named.

Main reasons for not taking part

  • Cannot give informed consent
  • Unclear or ambiguous diagnosis in the data

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Signed General Consent Form, or equivalent document
  • Confirmed diagnosis of Atopic Dermatitis

Who cannot take part

  • Inability to provide informed consent
  • Datasets with ambiguous or unclear diagnosis

Where in Switzerland

  • University of ZurichZurich, SwitzerlandContact: Julia-Tatjana Maul, Prof. Dr. med.Taking people

About the trial

What the trial wants to find out

The Global Healthcare Study on Atopic Dermatitis (GHSAD) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with atopic dermatitis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.

The group in the trial

  • Global Healthcare Study on Atopic Dermatitis

    Patients with Atopic Dermatitis

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Global Healthcare Study on Atopic Dermatitis
Plain-language title
A worldwide study of care and quality of life in atopic dermatitisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
22 June 2026